financetom
Business
financetom
/
Business
/
Sezzle Insider Sold Shares Worth $276,720, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sezzle Insider Sold Shares Worth $276,720, According to a Recent SEC Filing
Aug 27, 2025 1:40 PM

04:23 PM EDT, 08/27/2025 (MT Newswires) -- Paul Paradis, Director & President, on August 26, 2025, sold 3,000 shares in Sezzle ( SEZL ) for $276,720. Following the Form 4 filing with the SEC, Paradis has control over a total of 1,271,448 common shares of the company, with 528,382 shares held directly and 743,066 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1662991/000166299125000226/xslF345X05/wk-form4_1756325753.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
TPG RE Finance Closes $1.1 Billion Commercial Real Estate Collateralized Loan Obligation
TPG RE Finance Closes $1.1 Billion Commercial Real Estate Collateralized Loan Obligation
Mar 31, 2025
10:12 AM EDT, 03/31/2025 (MT Newswires) -- TPG RE Finance Trust ( TRTX ) said Monday it closed a $1.1 billion managed commercial real estate collateralized loan obligation on Friday. The company placed $962.5 million of investment-grade securities with institutional investors, providing it with term financing on a non-mark-to-market, non-recourse basis, it said, adding that the obligation has a 30-month...
Abbott Laboratories Says Trial Results Show Benefits of TriClip System for People With Leaky Heart Valves
Abbott Laboratories Says Trial Results Show Benefits of TriClip System for People With Leaky Heart Valves
Mar 31, 2025
10:05 AM EDT, 03/31/2025 (MT Newswires) -- Abbott Laboratories ( ABT ) said Monday new results from a trial showed that the TriClip transcatheter edge-to-edge repair system to treat leaky heart valves provided substantial and sustained improvements in the severity of the condition after two years. The data also showed that that the device significantly reduced the rate of heart...
NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation
NeOnc Technologies Holdings' Perillyl Alcohol Receives FDA's Rare Pediatric Disease Designation
Mar 31, 2025
10:03 AM EDT, 03/31/2025 (MT Newswires) -- NeOnc Technologies Holdings ( NTHI ) said Monday that the US Food and Drug Administration has granted rare pediatric disease designation to perillyl alcohol, also known as NEO100, for the treatment of pediatric-type diffuse high-grade gliomas. The company said the FDA designation was based on findings that pediatric-type diffuse high-grade gliomas meets the...
Gyre Therapeutics Says China's NMPA Approves Pirfenidone Trial in Lung Injury
Gyre Therapeutics Says China's NMPA Approves Pirfenidone Trial in Lung Injury
Mar 31, 2025
10:06 AM EDT, 03/31/2025 (MT Newswires) -- Gyre Therapeutics ( GYRE ) said Monday that China's National Medical Products Administration approved its application to conduct a clinical trial evaluating pirfenidone capsules for radiation-induced lung injury, with or without immune-related pneumonitis. The company said it expects to start the phase 2/3 trial to assess dosing and efficacy in H2 2025 at...
Copyright 2023-2026 - www.financetom.com All Rights Reserved